UnitedHealth/$UNH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About UnitedHealth
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Ticker
$UNH
Sector
Primary listing
NYSE
Employees
400,000
Headquarters
Website
UnitedHealth Metrics
BasicAdvanced
$320B
15.30
$23.12
0.44
$8.51
2.50%
Price and volume
Market cap
$320B
Beta
0.44
52-week high
$613.92
52-week low
$234.60
Average daily volume
20M
Dividend rate
$8.51
Financial strength
Current ratio
0.846
Quick ratio
0.765
Long term debt to equity
70.14
Total debt to equity
75.577
Dividend payout ratio (TTM)
36.54%
Interest coverage (TTM)
7.50%
Profitability
EBITDA (TTM)
33,577
Gross margin (TTM)
20.84%
Net profit margin (TTM)
5.04%
Operating margin (TTM)
7.27%
Effective tax rate (TTM)
16.94%
Revenue per employee (TTM)
$1,060,000
Management effectiveness
Return on assets (TTM)
6.46%
Return on equity (TTM)
21.65%
Valuation
Price to earnings (TTM)
15.298
Price to revenue (TTM)
0.764
Price to book
3.38
Price to tangible book (TTM)
-9.02
Price to free cash flow (TTM)
12.782
Free cash flow yield (TTM)
7.82%
Free cash flow per share (TTM)
27.664
Dividend yield (TTM)
2.41%
Forward dividend yield
2.50%
Growth
Revenue change (TTM)
9.70%
Earnings per share change (TTM)
52.72%
3-year revenue growth (CAGR)
11.31%
10-year revenue growth (CAGR)
11.83%
3-year earnings per share growth (CAGR)
6.50%
10-year earnings per share growth (CAGR)
13.91%
3-year dividend per share growth (CAGR)
12.36%
10-year dividend per share growth (CAGR)
18.01%
What the Analysts think about UnitedHealth
Analyst ratings (Buy, Hold, Sell) for UnitedHealth stock.
Bulls say / Bears say
Berkshire Hathaway’s purchase of 5 million UNH shares valued at about $1.57 billion signals confidence from a major investor and suggests the stock is undervalued for its long-term outlook. (Reuters)
UnitedHealth reinstated its full-year 2025 profit forecast, guiding for adjusted EPS of at least $16. This provides a framework for analysts and reflects management’s efforts to stabilize performance ahead of expected earnings growth in 2026. (Reuters)
For Q2 2025, UNH reported revenue of $111.6 billion, a 12.9% increase year-over-year that slightly beat Wall Street forecasts, highlighting ongoing demand across its UnitedHealthcare and Optum businesses. (Reuters)
UnitedHealth’s medical loss ratio rose to 89.4% in the second quarter, an increase of 430 basis points year-over-year, showing that medical costs are rising faster than prices and pressuring underwriting margins. (Reuters)
The U.S. Department of Justice is running a criminal investigation into UnitedHealth’s Medicare Advantage billing, creating financial and reputational risks from possible legal penalties. (Reuters)
CEO Andrew Witty abruptly resigned in May 2025 and Stephen Hemsley returned, highlighting instability at the top and raising execution risk as management seeks to rebuild investor trust. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 28 Aug 2025.
UnitedHealth Financial Performance
Revenues and expenses
UnitedHealth Earnings Performance
Company profitability
UnitedHealth News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept23
UnitedHealth
DividendPayment
$2.21Per share
FAQs
What’s the current market cap for UnitedHealth stock?
UnitedHealth (UNH) has a market cap of $320B as of September 16, 2025.
What is the P/E ratio for UnitedHealth stock?
The price to earnings (P/E) ratio for UnitedHealth (UNH) stock is 15.3 as of September 16, 2025.
Does UnitedHealth stock pay dividends?
Yes, the UnitedHealth (UNH) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $8.51 and the yield is 2.5%. UnitedHealth has a payout ratio of 36.54% on a trailing twelve-month basis.
When is the next UnitedHealth dividend payment date?
The next UnitedHealth (UNH) dividend payment is scheduled for September 23, 2025.
What is the beta indicator for UnitedHealth?
UnitedHealth (UNH) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.